Monday, May 19, 2014 7:23:02 PM
----
I like this part:
<What Mr. Market is overlooking
It's no secret that Wall Street squanders long-term opportunities when short-term pain or uncertainty arises -- and that's exactly what I think is happening here.
Foolish bottom line
I believe Mr. Market's focus on short-term uncertainty has created a solid opportunity for long-term investors. Momenta has a long way to go before realizing the full potential of its innovative platform, but it continues to make progress each quarter>
The rest of the opinion ain't bad either.
http://www.fool.com/investing/general/2014/05/19/ignore-copaxone-momenta-pharmaceuticals-still-a-bu.aspx
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM